Emmaus Life Sciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $73.8M | $51.5M | $813.0K |
| Jun 2022 | $80.6M | $46.0M | $982.0K |
| Sep 2022 | $79.8M | $42.2M | $1.2M |
| Dec 2022 | $82.3M | $48.2M | $2.0M |
| Mar 2023 | $84.9M | $48.9M | $1.8M |
| Jun 2023 | $85.3M | $50.3M | $1.4M |
| Sep 2023 | $83.8M | $47.5M | $1.5M |
| Dec 2023 | $82.9M | $35.2M | $2.5M |
| Mar 2024 | $83.2M | $29.5M | $1.7M |
| Jun 2024 | $83.0M | $25.9M | $1.5M |
| Sep 2024 | $81.1M | $27.3M | $1.3M |
| Dec 2024 | $80.1M | $23.6M | $1.4M |
| Mar 2025 | $81.1M | $22.5M | $1.3M |
| Jun 2025 | $79.0M | $23.3M | $886.0K |
| Sep 2025 | $80.2M | $20.8M | $293.0K |
| Dec 2025 | $85.0M | $21.4M | $2.1M |
| Mar 2026 | $86.6M | $18.7M | $1.1M |
| Jun 2026 | $82.5M | $16.4M | $2.8M |